Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keyvan Razazi

Showing results (121-130 of 142) with videos related to

Pageof 15
Sort By:
Scientific Reports|December 1, 2021
Nationwide retrospective study of critically ill adults with sickle cell disease in FranceMaïté Agbakou, Armand Mekontso-Dessap, Morgane Pere, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 27, 2025
Antifungal concentrations in mechanically ventilated COVID-19 patients with or without ECMO: The CAPADOSE observational retrospective multicenter StudyPaul Masi, Mickael Lescroart, Anne Veinstein, et al.
The Journal of Infection|December 16, 2024
Real-world multicentre study of cefiderocol treatment of immunocompromised patients with infections caused by multidrug-resistant Gram-negative bacteria: CEFI-IDSarah Soueges, Emmanuel Faure, Perrine Parize, et al.
American Journal of Respiratory and Critical Care Medicine|April 10, 2025
Comparison of Prophylactic and Therapeutic Doses of Anticoagulation for Acute Chest Syndrome in Sickle Cell Disease: The TASC Randomized Clinical TrialArmand Mekontso Dessap, Anoosha Habibi, Jean-Benoît Arlet, et al.
Annals of Intensive Care|February 9, 2021
Non-invasive ventilation alternating with high-flow nasal oxygen versus high-flow nasal oxygen alone after extubation in COPD patients: a post hoc analysis of a randomized controlled trialArnaud W Thille, Rémi Coudroy, Mai-Anh Nay, et al.
BMJ Open|April 27, 2022
Comparison of standard prophylactic, intermediate prophylactic and therapeutic anticoagulation in patients with severe COVID-19: protocol for the ANTICOVID multicentre, parallel-group, open-label, randomised controlled trialVincent Labbe, Damien Contou, Nicholas Heming, et al.
Annals of Intensive Care|March 3, 2021
Continuous positive airway pressure for respiratory support during COVID-19 pandemic: a frugal approach from bench to bedsideGuillaume Carteaux, Manuella Pons, François Morin, et al.
Chest|May 23, 2020
Pressure-Support Ventilation vs T-Piece During Spontaneous Breathing Trials Before Extubation Among Patients at High Risk of Extubation Failure: A Post-Hoc Analysis of a Clinical TrialArnaud W Thille, Rémi Coudroy, Mai-Anh Nay, et al.
Critical Care (London, England)|June 29, 2021
Non-invasive ventilation versus high-flow nasal oxygen for postextubation respiratory failure in ICU: a post-hoc analysis of a randomized clinical trialArnaud W Thille, Grégoire Monseau, Rémi Coudroy, et al.
JAMA Internal Medicine|March 22, 2023
Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia: The ANTICOVID Randomized Clinical TrialVincent Labbé, Damien Contou, Nicholas Heming, et al.
Pageof 15

Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
Scientific Reports|December 1, 2021
Nationwide retrospective study of critically ill adults with sickle cell disease in FranceMaïté Agbakou, Armand Mekontso-Dessap, Morgane Pere, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 27, 2025
Antifungal concentrations in mechanically ventilated COVID-19 patients with or without ECMO: The CAPADOSE observational retrospective multicenter StudyPaul Masi, Mickael Lescroart, Anne Veinstein, et al.
The Journal of Infection|December 16, 2024
Real-world multicentre study of cefiderocol treatment of immunocompromised patients with infections caused by multidrug-resistant Gram-negative bacteria: CEFI-IDSarah Soueges, Emmanuel Faure, Perrine Parize, et al.
American Journal of Respiratory and Critical Care Medicine|April 10, 2025
Comparison of Prophylactic and Therapeutic Doses of Anticoagulation for Acute Chest Syndrome in Sickle Cell Disease: The TASC Randomized Clinical TrialArmand Mekontso Dessap, Anoosha Habibi, Jean-Benoît Arlet, et al.
Annals of Intensive Care|February 9, 2021
Non-invasive ventilation alternating with high-flow nasal oxygen versus high-flow nasal oxygen alone after extubation in COPD patients: a post hoc analysis of a randomized controlled trialArnaud W Thille, Rémi Coudroy, Mai-Anh Nay, et al.
BMJ Open|April 27, 2022
Comparison of standard prophylactic, intermediate prophylactic and therapeutic anticoagulation in patients with severe COVID-19: protocol for the ANTICOVID multicentre, parallel-group, open-label, randomised controlled trialVincent Labbe, Damien Contou, Nicholas Heming, et al.
Annals of Intensive Care|March 3, 2021
Continuous positive airway pressure for respiratory support during COVID-19 pandemic: a frugal approach from bench to bedsideGuillaume Carteaux, Manuella Pons, François Morin, et al.
Chest|May 23, 2020
Pressure-Support Ventilation vs T-Piece During Spontaneous Breathing Trials Before Extubation Among Patients at High Risk of Extubation Failure: A Post-Hoc Analysis of a Clinical TrialArnaud W Thille, Rémi Coudroy, Mai-Anh Nay, et al.
Critical Care (London, England)|June 29, 2021
Non-invasive ventilation versus high-flow nasal oxygen for postextubation respiratory failure in ICU: a post-hoc analysis of a randomized clinical trialArnaud W Thille, Grégoire Monseau, Rémi Coudroy, et al.
JAMA Internal Medicine|March 22, 2023
Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia: The ANTICOVID Randomized Clinical TrialVincent Labbé, Damien Contou, Nicholas Heming, et al.
Pageof 15